Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EV-A71 Vaccine Consistency and Safety in Children (6-35 Months)
NCT03893747Phase 4Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Apr 2019
- Primary completion
- May 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of inactivated enterovirus 71 vaccine in HIV-associated central nervous system involvement (HAND), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Apr 2019; status: completed.
02
Drugs
inactivated enterovirus 71 vaccine
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT03893747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893747.